The 8 FRGs (ACSL3, FADS2, GLS2, HSF1, PANX1, PHKG2, VDAC2, and CDKN1A) that we selected to be associated with the diagnosis and prognosis of lung cancer have been shown to play important roles in cancer and tumor immunity. This evidence concerns the gene GLS2 and lung cancer.